Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Ulmann

Showing results (31-40 of 141) with videos related to

Pageof 15
Sort By:
Contraception|February 9, 2002
The pharmacokinetics of 750 microg levonorgestrel following administration of one single dose or two doses at 12- or 24-h intervalD Tremblay, E Gainer, A Ulmann
Contraception|September 6, 2001
Levonorgestrel-only emergency contraception: real-world tolerance and efficacyE Gainer, C Méry, A Ulmann
Lancet (London, England)|November 30, 1985
Transplacental passage of mifepristoneR Frydman, S Taylor, A Ulmann
FEBS Letters|July 28, 1980
Specific nuclear uptake of 24,25-dihydroxycholecalciferol, a vitamin D3 metabolite biologically active in cartilageM Corvol, A Ulmann, M Garabedian
Mineral and Electrolyte Metabolism|November 1, 1982
Early effects of 1 alpha,25-dihydroxy-vitamin D3 on phosphate absorption. A role for alkaline phosphatase?M Bachelet, B Lacour, A Ulmann
Endocrinology|July 1, 1975
Binding of glycyrrhetinic acid to kidney mineralocorticoid and glucocorticoid receptorsA Ulmann, J Menard, P Corvol
Annals of the New York Academy of Sciences|June 12, 1995
Clinical uses of mifepristone (MFP)A Ulmann, R Peyron, L Silvestre
Advances in Nephrology From the Necker Hospital|January 1, 1983
Disorders of calcium and phosphorus metabolism after successful kidney transplantationA Ulmann, N Chkoff, B Lacour
Biochemical and Biophysical Research Communications|July 27, 1979
Early stimulation of alkaline phosphatase activity in response to 1 alpha, 25-dihydroxycholecalciferolM Bachelet, A Ulmann, B Lacour
Lancet (London, England)|November 16, 1991
Development after in-utero exposure to mifepristoneA Ulmann, I Rubin, J Barnard
Pageof 15

Showing results (31-40 of 141) with videos related to

Sort By:
Pageof 15
Contraception|February 9, 2002
The pharmacokinetics of 750 microg levonorgestrel following administration of one single dose or two doses at 12- or 24-h intervalD Tremblay, E Gainer, A Ulmann
Contraception|September 6, 2001
Levonorgestrel-only emergency contraception: real-world tolerance and efficacyE Gainer, C Méry, A Ulmann
Lancet (London, England)|November 30, 1985
Transplacental passage of mifepristoneR Frydman, S Taylor, A Ulmann
FEBS Letters|July 28, 1980
Specific nuclear uptake of 24,25-dihydroxycholecalciferol, a vitamin D3 metabolite biologically active in cartilageM Corvol, A Ulmann, M Garabedian
Mineral and Electrolyte Metabolism|November 1, 1982
Early effects of 1 alpha,25-dihydroxy-vitamin D3 on phosphate absorption. A role for alkaline phosphatase?M Bachelet, B Lacour, A Ulmann
Endocrinology|July 1, 1975
Binding of glycyrrhetinic acid to kidney mineralocorticoid and glucocorticoid receptorsA Ulmann, J Menard, P Corvol
Annals of the New York Academy of Sciences|June 12, 1995
Clinical uses of mifepristone (MFP)A Ulmann, R Peyron, L Silvestre
Advances in Nephrology From the Necker Hospital|January 1, 1983
Disorders of calcium and phosphorus metabolism after successful kidney transplantationA Ulmann, N Chkoff, B Lacour
Biochemical and Biophysical Research Communications|July 27, 1979
Early stimulation of alkaline phosphatase activity in response to 1 alpha, 25-dihydroxycholecalciferolM Bachelet, A Ulmann, B Lacour
Lancet (London, England)|November 16, 1991
Development after in-utero exposure to mifepristoneA Ulmann, I Rubin, J Barnard
Pageof 15